There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 25 | 1115.7 |
| 2 | 112 | 1115.6 |
| 2 | 83 | 1115.5 |
| 2 | 26 | 1115.4 |
| 6 | 161 | 1115.2 |
| Ask | Qty | Orders |
|---|---|---|
| 1116 | 1 | 50 |
| 1116.1 | 1 | 43 |
| 1116.2 | 3 | 151 |
| 1116.3 | 5 | 194 |
| 1116.4 | 5 | 246 |
Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.
Zydus Lifesciences Limited is an India-headquartered lifesciences company with two integrated businesses: pharmaceuticals and consumer health and wellness . The company operates a network of 39 manufacturing facilities globally, 16 of which are USFDA inspected, underscoring its scale and quality focus; capabilities span oral solids, injectables, nasals, topicals, transdermal patches, and biologics including monoclonal antibodies and antibody–drug conjugates . Its global footprint is reflected in FY25 revenue from operations of Rs 232,415 million, with contributions from India (Rs 92,530 million), the US (Rs 111,411 million), and other markets (Rs 28,474 million).
A brief capital history dates back to May 15, 1995 (first equity allotment), with an Initial Public Offer (IPO) in February–March 2000, marking key milestones in its evolution . The company positions manufacturing as a strategic capability to deliver safe, effective and affordable medicines worldwide.
The intraday low for Zydus Lifesciences Ltd on the NSE today was ₹1,095.10. The stock's 52-week low stands at ₹835.50, recorded on 02 Apr 2026. Today's low is 31.07% above the 52-week low, indicating the stock is trading well above its yearly lows.
For Q4 FY26, Zydus Lifesciences Ltd reported: Revenue (Net Sales): ₹43888.00 Cr - Up 92.19% year-on-year from ₹22836.00 Cr in Q3 FY26. Net Income (PAT): ₹17220.00 Cr - Up 480.78% year-on-year from ₹2965.00 Cr in Q3 FY26.
The intraday high for Zydus Lifesciences Ltd on the NSE today (04 Jul 2026) was ₹1,142.90. This compares to the 52-week high of ₹1,142.90 recorded on 03 Jul 2026. Today's high was 0.00% above the 52-week high.
Yes,Zydus Lifesciences Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 23.50 per share between FY2022 and FY2026, with the most recent dividend of ₹1.00 per share for May 26, with an ex-dividend date of 24 Jul 2026. At the current market price of ₹1,140.60, the trailing dividend yield of Zydus Lifesciences Ltd stands at 14.00%.
Zydus Lifesciences Ltd has delivered a return of 31.66% over the last 3 months. The stock was trading at ₹866.30 on 06 Apr 2026 and is currently at ₹1,140.60 as of 04 Jul 2026, reflecting a Gain of ₹274.30 per share over this period.
Zydus Lifesciences Ltd has delivered 13.95% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,142.90 on 03 Jul 2026 and a 52-week low of ₹835.50 on 02 Apr 2026. It is currently trading at ₹1,140.60 as of 04 Jul 2026.
The all-time high (ATH) for Zydus Lifesciences Ltd was ₹1,300.90, recorded on 09 Aug 2024. At the current price of ₹1,140.60, the stock is trading 12.32% below its all-time high. The all-time low recorded was ₹86.21 on 22 Jan 2010.
Zydus Lifesciences Ltd has delivered a 77.13% absolute return over the past 5 years, equivalent to a CAGR of 12.11% per annum. The stock was priced at ₹643.93 in Jul 2021 and has risen to ₹1,140.60 as of 04 Jul 2026. An investment of ₹1,00,000 in Zydus Lifesciences Ltd five years ago would be worth ₹1,77,130.00 today.
As of 04 Jul 2026, the share price of Zydus Lifesciences Ltd is ₹1,140.60 on the NSE and ₹1,139.60 on the BSE. The stock opened at ₹1,105.00, touched a high of ₹1,142.90 and a low of ₹1,095.10 during today's session.
Over the last 6 months, Zydus Lifesciences Ltd has given a return of 23.72%. The stock was priced at ₹921.95 on 05 Jan 2026 and has Rise to ₹1,140.60 as of 04 Jul 2026, a change of ₹218.65 per share.
